Oncospace, founded in 2019 and headquartered in Baltimore, Maryland, is a medical device manufacturing company specializing in radiation oncology. The company's core mission is to personalize each patient’s treatment using an AI-based platform, aiming to minimize side effects and maintain the quality of life. Oncospace offers a cloud-native, AI-powered data analytics platform that enables clinicians to predict achievable plans, promote best practice behaviors, and share expertise seamlessly. Their market focus is on optimizing outcomes for radiation oncology patients, practices, and communities.
Notable affiliated people and investors have not been disclosed. However, Oncospace has achieved significant milestones, including receiving FDA clearance for their head and neck treatment platform. The company's AI-driven approach has had a meaningful impact on the field of radiation oncology by enhancing the precision and personalization of treatments, thereby improving patient outcomes and advancing clinical practices.
